Cost reduction of perioperative coagulation management in cardiac surgery: value of 'bedside' thrombelastography (ROTEM)

被引:155
作者
Spalding, Grit J.
Hartrumpf, Martin
Sierig, Tobias
Oesberg, Nils
Kirschke, Christian Guenther
Albes, Johannes M.
机构
[1] Heart Ctr Brandenburg, Dept Cardiovasc Surg, D-16321 Bernau, Germany
[2] Heart Ctr Brandenburg, Dept Anaesthesiol, Bernau, Germany
关键词
cardiac surgery; cost-reduction; coagulation management; blood product consumption;
D O I
10.1016/j.ejcts.2007.02.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Demographic changes and aggressive platelet inhibition have resulted in a marked increase in blood- and coagulation product expenditure and costs in cardiac surgery. We analyzed 'bedside' coagulation test (ROTEM) in order to verify clot forming quality for the purpose of finding a cost-effective treatment path. Methods: Annual treatment costs of all cardiosurgical patients were analyzed before (729 patients) and after (693 patients) implementation of 'bedside' ROTEM. Cumulative numbers and costs of platelet concentrates (PltC), fresh frozen plasma (FFP), red blood cell units (RBC), and coagulation factors: pooled coagulation concentrates (PCC), recombinant factor VIIa (rFVIIa), factor XIII (FXIII), and fibrinogen were assessed. Average monthly numbers and costs were compared. Number of resternotomies and early mortality was assessed and compared in both periods. Results: After ROMTEM implementation cumulative RBC expenditure showed 25% decrease white PltC exhibited 50% decrease. FFP expenditure remained unchanged. PCC, FXIII were markedly reduced (-80%) while rFVIIa were entirety omitted. Fibrinogen, however, increased two-fold. Cumulative average monthly costs of all blood products decreased from 66,000E to 45,000E (-32%). Coagulation factor average monthly costs decreased from 60,000E to 30,000E (-50%) yielding combined savings of 44%. In contrast, average monthly costs for ROTEM were 1.580E. Total number of resternotomies decreased from 6.6% to 5.5% white early mortality (5.9%; 6.0%) remained stable. Conclusion: Cumulative costs for treatment of perioperative coagulation disorders can be reduced by 'bedside' ROTEM analysis to achieve a selective substitution management. Saved costs for blood- and coagulation products clearly outweighed the expenses of ROTEM. Adequate differential coagulation management can therefore be cost-effective. (C) 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1052 / 1057
页数:6
相关论文
共 25 条
[1]   Physiological coagulation can be maintained in extracorporeal circulation by means-of shed blood separation and coating [J].
Albes, JM ;
Stöhr, IM ;
Kaluza, M ;
Siegemund, N ;
Schmidt, D ;
Vollandt, R ;
Wahlers, T .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (05) :1504-1512
[2]   Inflammatory response and platelet activation after off-pump coronary artery bypass surgery [J].
Aljassim, O ;
Karlsson, M ;
Wiklund, L ;
Jeppsson, A ;
Olsson, P ;
Berglin, E .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2006, 40 (01) :43-48
[3]   An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit [J].
Anderson, L ;
Quasim, I ;
Soutar, R ;
Steven, M ;
Macfie, A ;
Korte, W .
TRANSFUSION MEDICINE, 2006, 16 (01) :31-39
[4]   Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment [J].
Angiolillo, Dominick J. ;
Bernardo, Esther ;
Ramirez, Celia ;
Costa, Marco A. ;
Sabate, Manel ;
Jimenez-Quevedo, Pilar ;
Hernandez, Rosana ;
Moreno, Raul ;
Escaned, Javier ;
Alfonso, Fernando ;
Banuelos, Camino ;
Bass, Theodore A. ;
Macaya, Carlos ;
Fernandez-Ortiz, Antonio .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (02) :298-304
[5]   ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) [J].
Braunwald, E ;
Antman, EM ;
Beasley, JW ;
Califf, RM ;
Cheitlin, MD ;
Hochman, JS ;
Jones, RH ;
Kereiakes, D ;
Kupersmith, J ;
Levin, TN ;
Pepine, CJ ;
Schaeffer, JW ;
Smith, EE ;
Steward, DE ;
Theroux, P ;
Gibbons, RJ ;
Alpert, JS ;
Faxon, DP ;
Fuster, V ;
Gregoratos, G ;
Hiratzka, LF ;
Jacobs, AK ;
Smith, SC .
CIRCULATION, 2002, 106 (14) :1893-1900
[6]   Autotransfusion in cardiac surgery [J].
Cross, MH .
PERFUSION-UK, 2001, 16 (05) :391-400
[7]   Developing a blood conservation program in cardiac surgery [J].
DeAnda, Abe, Jr. ;
Baker, Kathy M. ;
Roseff, Susan D. ;
Green, Jeffrey A. ;
McCarthy, Harry ;
Aron, Tyrone ;
Spiess, Bruce D. .
AMERICAN JOURNAL OF MEDICAL QUALITY, 2006, 21 (04) :230-237
[8]  
DEPEPPO AP, 1995, TEX HEART I J, V22, P231
[9]  
Dilthey G, 1993, J Cardiothorac Vasc Anesth, V7, P425, DOI 10.1016/1053-0770(93)90164-G
[10]  
Drury Nigel E, 2006, Expert Rev Cardiovasc Ther, V4, P535, DOI 10.1586/14779072.4.4.535